Acute, generalised but transient muscle cramping and weakness shortly after first oxaliplatin infusion.
Elisabeth
E
Krexner
Anika
A
Stickler
Christian
C
Prainer
Josef
J
Finsterer
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003110:Colonic Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009120:Muscle Cramp / Q000139:chemically induced*; D018908:Muscle Weakness / Q000139:chemically induced*; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D000077150:Oxaliplatin
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin